These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36287192)

  • 1. Protecting glomerulus: role of angiotensin-II type 2 receptor.
    Patel S; Kulkarni K; Hussain T
    Clin Sci (Lond); 2022 Oct; 136(20):1467-1470. PubMed ID: 36287192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type-2-receptor stimulation ameliorates focal and segmental glomerulosclerosis in mice.
    Liao MC; Miyata KN; Chang SY; Zhao XP; Lo CS; El-Mortada MA; Peng J; Chenier I; Yamashita M; Ingelfinger JR; Chan JSD; Zhang SL
    Clin Sci (Lond); 2022 May; 136(10):715-731. PubMed ID: 35502764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fn14 in podocytes and proteinuric kidney disease.
    Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
    Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.
    Szabó T; Ambrus L; Zákány N; Balla G; Bíró T
    Acta Physiol Hung; 2015 Sep; 102(3):241-51. PubMed ID: 26551740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
    Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
    FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte injury at young age causes premature senescence and worsens glomerular aging.
    Veloso Pereira BM; Zeng Y; Maggiore JC; Schweickart RA; Eng DG; Kaverina N; McKinzie SR; Chang A; Loretz CJ; Thieme K; Hukriede NA; Pippin JW; Wessely O; Shankland SJ
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F120-F134. PubMed ID: 37855038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
    Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
    Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T; Sloan AJ; Hoenderop JG; Flesche J; van Goor H; Kistler AD; Bakker M; Bindels RJ; de Boer RA; Möller CC; Hamming I; Navis G; Wetzels JF; Berden JH; Reiser J; Faul C; van der Vlag J
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
    Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress.
    Raij L; Tian R; Wong JS; He JC; Campbell KN
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
    Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
    Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
    Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability factors in focal and segmental glomerulosclerosis.
    Reiser J; Nast CC; Alachkar N
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):417-21. PubMed ID: 25168830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLEC14A protects against podocyte injury in mice with adriamycin nephropathy.
    Su Z; Li Y; Lv H; Cui X; Liu M; Wang Z; Zhang Y; Zhen J; Tang W; Wang X; Yi F
    FASEB J; 2021 Jul; 35(7):e21711. PubMed ID: 34107098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Podocyte-specific RAP1GAP expression contributes to focal segmental glomerulosclerosis-associated glomerular injury.
    Potla U; Ni J; Vadaparampil J; Yang G; Leventhal JS; Campbell KN; Chuang PY; Morozov A; He JC; D'Agati VD; Klotman PE; Kaufman L
    J Clin Invest; 2014 Apr; 124(4):1757-69. PubMed ID: 24642466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD147/Basigin Deficiency Prevents the Development of Podocyte Injury through FAK Signaling.
    Yoshioka T; Kosugi T; Masuda T; Watanabe T; Ryuge A; Nagaya H; Maeda K; Sato Y; Katsuno T; Kato N; Ishimoto T; Yuzawa Y; Maruyama S; Kadomatsu K
    Am J Pathol; 2019 Jul; 189(7):1338-1350. PubMed ID: 31014956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Super-resolved local recruitment of CLDN5 to filtration slits implicates a direct relationship with podocyte foot process effacement.
    Tesch F; Siegerist F; Hay E; Artelt N; Daniel C; Amann K; Zimmermann U; Kavvadas P; Grisk O; Chadjichristos C; Endlich K; Chatziantoniou C; Endlich N
    J Cell Mol Med; 2021 Aug; 25(16):7631-7641. PubMed ID: 34156149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis.
    Otalora L; Chavez E; Watford D; Tueros L; Correa M; Nair V; Ruiz P; Wahl P; Eddy S; Martini S; Kretzler M; Burke GW; Fornoni A; Merscher S
    PLoS One; 2019; 14(10):e0222948. PubMed ID: 31581251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis.
    Hu S; Han R; Shi J; Zhu X; Qin W; Zeng C; Bao H; Liu Z
    J Biol Chem; 2018 Dec; 293(52):20227-20239. PubMed ID: 30389788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.